PubMed Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., Zarkovic, N., Borovic, S., Srdjak, M., Hajdar, S., Kopljar, M., Batelja, L., Boban-Blagaic, A., Turcic, I., Amic, F., Ruenzi, E., Rucman, R., Seiwerth, S., Sikiric, P
As side effects diminish and weight loss benefits accumulate, the indirect risk factors that drive UTI vulnerability decrease while protective factors increase
Obesity contributes to the reproductive and metabolic abnormalities characterizing this syndrome
[38] This last measurement indicates that Berbevis may help promote loss of fat preferentially and preserves muscle mass